• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺嘌呤磷酸核糖基转移酶缺陷导致的 2,8-二羟腺嘌呤尿晶体肾病的异常病程。

An Unusual Course of a 2,8-Dihydroxyadeninuria Crystalline Nephropathy Secondary to Adenine Phosphoribosyltransferase Deficiency.

机构信息

Nephrology Department, Hôtel-Dieu de France, Saint Joseph University, Beirut, Lebanon.

Pathology Department, Hôtel-Dieu de France, Saint Joseph University, Beirut, Lebanon.

出版信息

Nephron. 2021;145(5):503-507. doi: 10.1159/000516281. Epub 2021 May 27.

DOI:10.1159/000516281
PMID:34044400
Abstract

Adenine phosphoribosyltransferase (APRT) deficiency is a rare disorder caused by an autosomal recessive genetic disease leading to the deposition of 2,8-dihydroxyadenine (2,8-DHA) in the kidney. The disease remains under-recognized, oftentimes diagnosed in late stages of renal insufficiency or a failed kidney allograft with biopsy-proven disease recurrence. Here, we present the case of a 59-year-old middle eastern male patient diagnosed with 2,8-DHA nephropathy after a very unusual presentation, and we show how the initiation of an appropriate therapy slowed down his evolution toward kidney replacement therapies. His disease was found to be secondary to a specific APRT gene variant c.188G>A p (Gly63Asp) also described in 4 other patients, all from middle eastern origins.

摘要

腺嘌呤磷酸核糖基转移酶(APRT)缺陷是一种罕见的疾病,由常染色体隐性遗传疾病引起,导致肾脏中沉积 2,8-二羟腺嘌呤(2,8-DHA)。这种疾病仍然认识不足,通常在肾功能不全的晚期或移植肾活检证实疾病复发时才被诊断出来。在这里,我们介绍了一名 59 岁的中东男性患者的病例,他以非常不寻常的表现被诊断为 2,8-DHA 肾病,我们展示了如何启动适当的治疗来减缓他向肾脏替代治疗的进展。他的疾病被发现是由 APRT 基因的特定变体 c.188G>A p (Gly63Asp)引起的,该变体也在另外 4 名来自中东的患者中被描述。

相似文献

1
An Unusual Course of a 2,8-Dihydroxyadeninuria Crystalline Nephropathy Secondary to Adenine Phosphoribosyltransferase Deficiency.腺嘌呤磷酸核糖基转移酶缺陷导致的 2,8-二羟腺嘌呤尿晶体肾病的异常病程。
Nephron. 2021;145(5):503-507. doi: 10.1159/000516281. Epub 2021 May 27.
2
Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation.非布司他用于预防肾移植后因腺嘌呤磷酸核糖转移酶缺乏所致的复发性2,8-二羟基腺嘌呤肾病
Intern Med. 2017;56(11):1387-1391. doi: 10.2169/internalmedicine.56.8142. Epub 2017 Jun 1.
3
Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with Adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial.腺嘌呤磷酸核糖转移酶缺陷症(APRTd)患者中别嘌醇和非布司他对尿 2,8-二羟腺嘌呤排泄影响的比较:一项临床试验。
Eur J Intern Med. 2018 Feb;48:75-79. doi: 10.1016/j.ejim.2017.10.007. Epub 2017 Dec 12.
4
Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure.复发性2,8 - 二羟基腺嘌呤肾病:肾移植失败的一种罕见但可预防的原因。
Am J Transplant. 2014 Nov;14(11):2623-32. doi: 10.1111/ajt.12926. Epub 2014 Oct 10.
5
Unusual cause of crystalline nephropathy.结晶性肾病的罕见病因。
Saudi J Kidney Dis Transpl. 2018 Mar-Apr;29(2):462-465. doi: 10.4103/1319-2442.229280.
6
Optimization and validation of a UPLC-MS/MS assay for simultaneous quantification of 2,8-dihydroxyadenine, adenine, allopurinol, oxypurinol and febuxostat in human plasma.建立并验证了一种超高效液相色谱串联质谱法(UPLC-MS/MS),用于同时定量检测人血浆中的 2,8-二羟腺嘌呤、腺嘌呤、别嘌醇、氧嘌呤醇和非布司他。
J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Mar 1;1235:124041. doi: 10.1016/j.jchromb.2024.124041. Epub 2024 Feb 5.
7
Adenine phosphoribosyltransferase deficiency as a rare cause of renal allograft dysfunction.腺嘌呤磷酸核糖基转移酶缺乏症致肾移植术后肾功能不全 1 例
J Am Soc Nephrol. 2014 Apr;25(4):671-4. doi: 10.1681/ASN.2013090960. Epub 2014 Jan 23.
8
Kidney Transplant Outcomes in Patients With Adenine Phosphoribosyltransferase Deficiency.腺嘌呤磷酸核糖基转移酶缺陷患者的肾移植结局。
Transplantation. 2020 Oct;104(10):2120-2128. doi: 10.1097/TP.0000000000003088.
9
Adenine phosphoribosyltransferase deficiency.腺嘌呤磷酸核糖基转移酶缺乏症。
Clin J Am Soc Nephrol. 2012 Sep;7(9):1521-7. doi: 10.2215/CJN.02320312. Epub 2012 Jun 14.
10
Urinary 2,8-dihydroxyadenine excretion in patients with adenine phosphoribosyltransferase deficiency, carriers and healthy control subjects.腺嘌呤磷酸核糖基转移酶缺陷症患者、携带者和健康对照者的尿 2,8-二羟腺嘌呤排泄。
Mol Genet Metab. 2019 Sep-Oct;128(1-2):144-150. doi: 10.1016/j.ymgme.2019.05.015. Epub 2019 May 28.

引用本文的文献

1
Adenine phosphoribosyltransferase (APRT) deficiency: an increasingly recognized disease.腺嘌呤磷酸核糖转移酶(APRT)缺乏症:一种日益被认识的疾病。
Int Urol Nephrol. 2025 Feb 21. doi: 10.1007/s11255-025-04420-6.